Summary.-An analysis of the constituents of the plasma membrane of a methylcholanthrene-induced sarcoma (the MCI tumour) in a hooded rat revealed four tumour-associated macromolecules. Two of these were antigenic in the syngeneic host, one was unique to the MC1 tumour and could not be detected in embryo tissue and has the properties to be expected from the well established tumour-specific transplantation-type antigen while the other, referred to as OEA I, was present in all rat sarcomata tested as well as in early embryos. Two other embryonic components were detected in the sarcoma but these were not immunogenic in the rat.
Summary.-An analysis of the constituents of the plasma membrane of a methylcholanthrene-induced sarcoma (the MCI tumour) in a hooded rat revealed four tumour-associated macromolecules. Two of these were antigenic in the syngeneic host, one was unique to the MC1 tumour and could not be detected in embryo tissue and has the properties to be expected from the well established tumour-specific transplantation-type antigen while the other, referred to as OEA I, was present in all rat sarcomata tested as well as in early embryos. Two other embryonic components were detected in the sarcoma but these were not immunogenic in the rat. The properties of these tumour-associated " antigens " in the membrane of rat sarcomata are summarized below: proce- dures tumour cells are rejected. TSTAs, when assayed by graft rejection and in vitro cytotoxicity tests, appear not to cross-react and to be unique for each particular chemically-induced tumour. In addition to these antigens which are unique to each individual tumour there are tumour-associated macromolecules which are common to many tumours; frequently these are substances normally found only in embryonic life. Against virally induced sarcomata of the hamster such embryonic antigens induce graft rejection (Coggin, Ambrose and Anderson, 1971) but in other tumour systems the presence of embryonic antigens has usually been identified by xenogeneic antisera and referred to as tumour-antigens, but this is in some respects a misnomer since they may not be antigenic in the syngeneic host. Stonehill and Bendich (1970) using xenogeneic antiserum, provided evidence for such one " antigen " present in a wide variety of mouse tumours, embryos and adult skin but no other adult tissue. Baldwin, Glaves and Pimm (1971) found that the serum from syngeneic multiparous rats bound to the membranes of many rat tumours, and interpreted this as indicating the presence of an embryonic substance, but this did not appear to be antigenic in the tumour bearing host.
However, hypersensitivity tests showed that chemically induced rat sarcomata contain in addition to the TSTA unique to each tumour, a tumourspecific material common to all sarcomata tested, against which the tumour bearing host reacts (Wang, 1968) . This common tumour antigen was shown to be of embryonic origin (Alexander, 1971) .
Recently Taranger et al. (1972) reported that papillomata and carcinomata induced in the bladder of mice and rats contain a common antigen against which the tumour bearing host mounts a cellmediated immune response. This antigen appeared to be confined to bladder tumours and was not found in chemicallyinduced sarcomata and may therefore differ from that reported in sarcomata by Wang (1968) and Alexander (1971) .
In Stonehill and Bendich (1970) and the other has some similarities to the carcino-embryonic antigen (CEA) of human gastro-intestinal tract tumours (Gold and Freedman, 1965) . These findings gave us the opportunity to assess the potential role of embryonic antigens and to elucidate the relationship of embryonic " antigens " reported by others using xenogeneic antisera, to that detected by the syngeneic tumour immune serum. This study was also designed to obtain information about the location and some physicochemical properties of the embryonic antigens and to compare these with the TSTA.
MATERIALS AND METHODS
Rats.-Inbred male hooded rats were used throughout and their genetic identity established by skin grafting.
Tunmours.-A transplanted sarcoma MC-I, originally induced by 20methylcholanthrene subcutaneously, was selected for study because of its strong immunogenicitv and non-cross reaction as judged by standard transplantation tests. All tumours were grown intramuscularly in a hind lim b and surgically excised when 2-3 cm in diameter. Early generations were stored at liquid nitrogen temperature and withdrawn at intervals for passage in syngeneic hooded rats and tests were carried out on tumours from generation 5-17. Other tumours used for comparison were spontaneous or were induced by chemicals or irradiation.
Embryonic tissues-These were obtained free of maternal tissue from syngeneic hooded rats at two different gestational periods; 9-11 days and 15-17 days. (c) Crude membrane fraction8.-Finely minced MC-J tumour was suspended in a 0-25 mol/l sucrose buffer (2 mmol/l MgCI2, 2 mmol/l, CaCI2, 1 mmol/l NaHCO3) pH 7 6, and homogenized with an ultra-turrax, in a controlled manner so that the nuclei remained intact (Baldwin and Glaves, 1972) . The resulting tumour homogenate was centrifuged (at 600 g for 12 min) to remove nuclei and debris, and the supernatant was kept. The pellet was resuspended in sucrose buffer and centrifuged, and this step was repeated three times. The pooled supernatants were then centrifuged (at 90,000 g for 2 hours) and the pelleted membranes were dispersed in either phosphate buffered saline or 5 mmol/l Tris-HCl buffer, pH 7-6. ( The rats then received 6 injections over 3 months of a mechanically prepared and (15,000 rad) irradiated MC-1 tumour cell suspension at multiple sites, including intraperitoneal. Rats were bled after the sixth injection and subsequent bleeding § were preceded by an additional immunization.
(b) Xenogeneic antiserum.-The regimen consisted of 3 injections over 2 weeks (at multiple intramuscular sites) of a given lyophilized antigen resuspended in sterile distilled water at 5 mg/ml and emulsified with equal volumes of complete Freund's adjuvant. Booster injections of 2 ml were prepared with incomplete Freund's adjuvant and administered subcutaneously at the fourth week. Blood was collected 2 weeks later and subsequent bleedings were preceded by an additional booster of an emulsion of incomplete Freund's adjuvant and the antigen extract.
Absorption procedures
The initial absorption of the xenogeneic antisera was performed with normal rat serum that had been insolubilized by crosslinking with glutaraldehyde (Avrameas and Ternynck, 1969) . Further absorptions were by addition of an excess of a lyophilized pool of aqueous extracted syngeneic rat tissue, comprising heart, lung, liver, spleen, gut, skin, skeletal muscle and connective tissue. Approximately 75-150 mg of lyophilized normal tissue extracts were needed to absorb fully 1 ml of xenogeneic antisera. The reaction mixture was incubated for 1 hour at RT, then 18 hours at 4°C when it was clarified by centrifugation (20 min at 20,000 g; 4VC). In the instance of xenogeneic antiserum to the MC-1 perchloric acid tumour extract, absorptions were performed with perchloric acid extracted normal serum (30-50 mg) and tissues (20-30 mg).
Assay techniques
(1) Indirect membrane immunofluorescence was performed on viable single tumour cell suspensions obtained from finely minced solid tumour with 0.04% trypsin and 0.04% collagenase in the presence of a small amount of DNAase. When xenogeneic antiserum was tested, lymphocyte suspensions prepared from teased normal hooded rat spleens were used as controls. Xenogeneic antiserum was used at dilutions 1/5 to 1/40. Syngeneic tumour immune serum was tested at dilutions 1/4 to 1/12. The appropriate fluoresceinconjugated antiserum to rat y-globulins or rabbit y-globulins (Wellcome Reagents) was used at 1 : 12 dilution. In order to quantitate the results, fluorescent indices (FI) were calculated:
% staining of cells Fl = with specific antiserum % staining of cells with normal serum A reaction was defined as positive when the FI was equal to, or greater than 2-5 for both syngeneic and xenogeneic antisera.
(2) Inhibition of membrane immunofluorescence.-The antigenic activity in the various samples of lyophilized tissue extracts or their concentrated chromatographic fractions was detected and quantitated by their capacity to inhibit antiserum from binding to its cell surface antigens on viable MC-1 tumour cells.
The lyophilized antigens were added in equal amounts by weight to the appropriately diluted antiserum. In the instance of antigens already in solution, the antiserum was diluted with this. The mixtures were incubated for 1 hour at RT, then overnight at 4°C and clarified before use (20 min at 4,000 g; 4°C). The amount of antibody not complexed to antigen was assayed by membrane immunofluorescence. The presence of specific antigen in the sample reduced the fluorescent index compared with that obtained with antisera alone or antisera incubated with normal tissue extracts.
(3) Immunodiffusion-This was performed in 1/O Agar (Difco) with the addition of 2.5% polyethylene glycol (6,000 MW) in barbitol buffer (pH 8.2) (Harrington, Fenton and Pert, 1971) . The wells had an outside diameter of 5 mm, and 3 mm separation, and these were filled and the slides incubated at 37°C for 24 hours in a moist chamber and continued for 7 days at 4°C to observe the development of additional precipitin lines. The technique of ICD of Darcy (1972) was also employed to detect soluble Ag-Ab complexes. At the time of testing, the lyophilized material was resuspended in a minimum volume of distilled water. Protein concentrations of these final tissue extracts as determined by spectrophotometric absorbence at 280 nm wave length (albumin standard) ranged from 50-60 mg/ml.
(4) Precipitation-inhibition assay.-This technique was employed to detect antigens present in concentrations too low to give precipitation reactions by immunodiffusion. The lyophilized material to be studied was added to the antiserum and incubated overnight at 4°C. The control unabsorbed, and the absorbed test antisera were added to the outside wells with the antigen standard in the centre well. The presence of antigen in any lyophilized tissue extract used to absorb the test sera resulted in the retardation of the movement of the precipitation reaction towards the centre well.
(5) Chromatographic fractionation of extracts. -Column chromatography was carried out in 4 cm2 x 55 cm columns packed with Biogel A05 m, Al 5 and P-150, equilibrated and eluted with 041 mol/l Tris, 0-2 mol/l NaCl and 1 mmol/l EDTA buffer titrated to pH 8 with HCI at 4°C. The columns were calibrated with proteins of known molecular weight and a graph of the E,/Eo against log MW plotted for each column. Samples collected from one or more runs -were concentrated in an Amicon ultra-filtration cell using PM-10 membranes and assayed by immunodiffusion or inhibition of memrbrane immunofluorescence.
RESULTS
In this investigation tumour-associated macromolecules were studied principally by the binding of antisera to viable cells. The test therefore only provides data on macromolecules present in or on the plasma membrane of tumour cells. It is quite possible that of the four cell surface components to be described some may also be found in the cytoplasm of the cell and there may be further tumour-associated macromolecules which are found only in the cytoplasm.
(1) Two tumour membrane components antigenic in the syngeneic host; the TSTA, and an onco-embryonic antigen (OEA I).
The present investigation began with the finding that serum of rats hyperimmunized with syngeneic MC-I sarcoma contained antibodies to two apparently different antigens in the membrane of the sarcoma cells. As Pilch and Riggins (1966) and Baldwin and Barker (1967) had observed, such sera reacted strongly with the membrane of the tumour used for immunization (Table I) . Unlike the finding of these authors, however, the syngeneic serum against the MC-J sarcoma also contained antibody which reacted, albeit very weakly, with the membrane of most of the other rat tumours studied (Table I) (Wreir and Elson, 1969) were removed, the FL on unrelated tumours was not lowered.
To study the nature of the commoncross-reacting antigen, MC-I tumour-immune serum was incubated with unrelated MC-3 sarcoma cells or various other tissue extracts. It was then tested on MC-I cells and unrelated MC-3 cells to determine whether the antibody to the cross-reacting antigen had been specifically absorbed (Table II) . As the data shows, the 9-11 day gestation embryonic extract lowered the FL index, but the 15-18 day embryonic, the normal tissue, and placental extracts did not. Also, absorption Stonehill and Bendich (1970) have demonstrated that antisera raised against aqueotus extracts of embryonic tissues cross-reacted with extracts from mouse tumours. Adopting a similar procedure we obtained Xenogeneic Antiserum III raised against aqueous extracts of 9-11 day old embryos and absorbed it with normal adult tissues (excluding skin). This produced a precipitin reaction with a component which was present in aqueous extracts of every rat tumour tested, and gave a line of complete identity with embryonic tissue extract (Fig. 2) . This material which will be referred to as OEA III, did not cross-react with OEA II, the antigen extracted from tumours with perchloric acid. In fact, OEA III (Mann et al., 1969) or 3-0 mol/I KCI (Reisfeld et al., 1971) . These treatments also release the tumour-associated membrane antigens (Baldwin and Glaves, 1972; Meltzer et al., 1971) (Fig. 3) . This suggests that papain No OEA I activity was found in the papain or KCI extract by inhibition of membrane immunofluorescence, but it is possible that its presence was undetected for quantitative reasons.
The partially purified water-soluble TSTA isolated by exclusion chromatography as described above was immunogenic in the rabbit and produced In general, the TSTA of each chemically-induced tumour is unique whether detected by rejection studies or more extensively by in vitro examination of tumour immune reactions. In the present study no evidence was found to suggest that the TSTA of MC-I sarcoma is the product of repressed genes.
The TSTA of chemically-induced hepatomata have been solubilized by others (Baldwin and Glaves, 1972; Meltzer et al., 1971) , using techniques developed for obtaining water-soluble transplantation antigens. Here, from the MC-I sarcoma, water-soluble TSTA was obtained by the two methods described. In both methods, a similar crude antigenic moiety was found with a mol. wt., estimated by Biogel filtration, of 40-50,000. The soluble TSTA is biologically active as shown by its inhibition of MC-J tumour-immune serum in membrane immunofluorescence and its capacity to raise xenogeneic antiserum. In other experiments (Thomson, Steele and Alexander, 1973) excess soluble TSTA and TSTA-antibody complexes have been detected in the circulation of tumour-bearing animals.
In man, have shown by a radioimmunoassay that colonic tumours also release a cell surface component, CEA, into the circulation. With the ability to obtain water-soluble TSTA it should be possible in the future to define chemically the nature of the tumourspecific rejection antigens. The second class of components which were found on the tumour cell surface by membrane immunofluorescence were common to most of the tumours studied. The syngeneic antibody to these antigens was specifically absorbed by early embryonic tissues whereas late embryonic and adult tissues did not lower the antibody titres. The OEA I (onco-embryonic antigen) was located on crude membrane fragments but attempts so far to isolate it in a soluble form have been unsuccessful. In a somewhat analogous situation, a few humans with cancer have a precipitating antibody in their sera that defines a new antigen associated with human neoplasia (Edynack et al., 1972) . This soluble antigen, named y-feto-protein, h-as been demonstrated to be present in extracts of a proportion of tumours of all histological types and it occurs in serum and some tissues of the foetus. Like the OEA I antigen of the rat the demonstration in man of the y-feto-protein is dependent entirely on the use of antibody occurring naturally rather than xenogeneic antiserum. Although the data rule out the possibility of cell surface auto-antigens accounting for the cross-reaction, it may still be possible that the OEA I is represented in normal adult tissues in a cryptic form unavailable to the host immune mechanism.
In man the immune reaction of the host directed against surface antigens (TSTA) of the autochthonous tumour, as assayed by the cytotoxic action of peripheral lymphocyte tumour cells in vitro, appears to be directed principally against antigens shared by all the tumours of the same histological type (Hellstrom et al., 1971) . Tumours induced in experimental animals on the other hand both by in vitr o cytotoxicity tests and by in vivo transplantation immunity evoke a reac-tion directed against a TSTA which is unique for each tumour and there appears to be no cross-reactivity-the only exception reported so far is for bladder papillomata (Taranger et al., 1972) . The present investigation may resolve this apparent discrepancy because in the serum of syngeneic rats, antibodies were found which were specific to the MC-J tumour (i.e. the MC-I TSTA) and to another surface component (OEA I) which is present in the membrane of all rat sarcomata tested, and in 9-11 day old embryos but not in older embryos or in the placenta. While OEA I does not appear to evoke a degree of resistance sufficient to be detectable by rejection of tumour cells it clearly evokes an antibody response and may also be responsible for cross-reacting delayed hypersensitivity reactions previously reported for rat sarcomata (Wang, 1968; Alexander, 1971) . It seems quite possible that when the TSTA is very strong it obscures the immune reaction against antigens of the OEA I type whereas in other situations, and this may conceivably apply to man, unique TSTA may be very weak or absent and measurements of host response therefore focus on the reaction against a cross-reacting antigen like OEA I.
The recurrence of the onco-embryonic antigens in tumours can be ascribed to alterations in the pattern of gene regulation accompanying neoplastic transformation. Similarly, the third class of component expressed on the tumour surface of rat sarcomata may be the result of genetic derepression. In this instance, the onco-embryonic components (OEA II and III) are not antigenic to the host. This probably results from their continuing presence in adult tissues since the genes governing their synthesis are not fully repressed. The universal appearance of these primitive components on the cell membrane may indicate that they have an important role in determining the social behaviour of the tumour cell. At present, however, the biological function of the primitive components is entirely unknown.
